AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Flora Growth Corp (NASDAQ:FLGC)
-- USD
0.000 0.000%Sponsored Reports
Loading...
| Previous Close (in USD) | -- |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 5.480/0.630 |
| EBITDA (in USD) | -8.448M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -6.24 |
| Total Assets (in USD) | 23.626M |
|---|---|
| Total Liabilities (in USD) | 17.222M |
| Revenue TTM (in USD) | 74.783M |
| Cash (in USD) | 4.385M |
| Market Cap (in USD) | 16.661 M |
| Revenue Per Share TTM | 9.436 |
| Gross Profit TTM (in USD) | 2.425M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Flora Growth Corp
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
3406 SW 26th Terrace, Fort Lauderdale, FL, United States, 33132
954 842 4989
Employees: 97
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Luis Merchan | Pres, CEO & Chairman | 1981 |
| 2. | Dr. Bernard Raymond Wilson F.C.A., FCA, FCPA, ICD.D, LLD(H) | Advisor | 1943 |
| 3. | Mr. Elshad Garayev CPA, CPA | Chief Financial Officer | NA |
| 4. | Mr. Matthew S. Cohen | Gen. Counsel | 1966 |
| 5. | Ms. Jessie Casner | Chief Marketing Officer | 1988 |
| 6. | Mr. James Choe | Chief Strategy Officer | 1979 |
| 7. | Mr. Aaron Atin | Corp. Sec. | 1984 |
| 8. | Mr. Javier Franco | VP Agriculture | 1968 |
| 9. | Ms. Holly Bell | VP of Regulatory Affairs | NA |
| 10. | Mr. Clifford A. Starke | CEO & Director | 1985 |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
+1.450 1.877% | 77.73 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
0.000 0.000% | 30.45 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
0.000 0.000% | 157.12 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
GALDY
GALDERMA GROUP AG |
-0.330 0.763% | 43.55 | 74.210 | 41.667 | 8.636 | 5.553 | 9.151 | 42.220 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Income Before Tax | -54.167M | -21.459M | -14.334M | - |
| Minority Interest | 0.214M | 0.112M | -0.113M | -0.011M |
| Net Income | -52.629M | -21.361M | -14.259M | - |
| Selling General Administrative | 24.86M | 17.44M | 11.847M | - |
| Gross Profit | 14.414M | 2.425M | 0.071M | - |
| Reconciled Depreciation | 2.629M | 0.765M | 0.113M | - |
| Ebit | 3.293M | -19.716M | -12.336M | -3.383M |
| Ebitda | 5.922M | -18.951M | -12.223M | - |
| Depreciation And Amortization | 2.629M | 0.765M | 0.113M | - |
| Operating Income | 3.293M | -18.951M | -12.336M | - |
| Other Operating Expenses | 62.636M | 21.376M | 12.501M | - |
| Interest Expense | 0.056M | 0.084M | 0.03M | 0M |
| Tax Provision | -1.538M | -0.098M | - | - |
| Interest Income | 0.056M | - | - | - |
| Net Interest Income | 0.056M | -0.084M | -0.03M | - |
| Income Tax Expense | -1.538M | -0.098M | -0.075M | - |
| Total Revenue | 37.171M | 8.98M | 0.106M | - |
| Total Operating Expenses | 39.879M | 21.376M | 12.466M | - |
| Cost Of Revenue | 22.757M | 6.555M | 0.035M | - |
| Total Other Income Expense Net | -57.46M | -2.508M | -1.998M | - |
| Net Income From Continuing Ops | -52.629M | -21.361M | -14.334M | - |
| Net Income Applicable To Common Shares | - | -21.249M | -14.17M | -3.389M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 23.626M | 80.987M | 85.479M | 19.452M | 1.173M |
| Intangible Assets | 0.946M | 18.096M | 9.736M | 0.658M | 0.567M |
| Other Current Assets | 1.368M | 0.978M | 0.037M | 0.347M | 0.21M |
| Total Liab | 17.222M | 24.575M | 8.538M | 3.202M | 2.478M |
| Total Stockholder Equity | 6.404M | 56.823M | 77.166M | 16.363M | -1.294M |
| Other Current Liab | 8.439M | 7.425M | 0.061M | 0.605M | 1.149M |
| Common Stock | - | - | 102.428M | 27.254M | 1.4M |
| Capital Stock | 0M | 0M | 102.428M | 27.254M | 1.4M |
| Retained Earnings | -142.549M | -90.865M | -38.536M | -17.287M | -2.824M |
| Good Will | 0M | 23.372M | 20.054M | 0.431M | - |
| Other Assets | - | - | 0.097M | - | - |
| Cash | 4.385M | 9.537M | 37.614M | 15.523M | 0.14M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 16.28M | 17.447M | 6.119M | 2.743M | 2.232M |
| Current Deferred Revenue | - | - | - | - | - |
| Net Debt | -0.713M | -5.394M | -36.276M | -14.874M | 1.189M |
| Short Term Debt | 2.73M | 2.274M | 0.43M | 0.329M | 1.083M |
| Short Long Term Debt | 1.931M | 1.086M | 0.018M | 0.251M | 1.03M |
| Short Long Term Debt Total | 3.672M | 4.143M | 1.338M | 0.649M | 1.329M |
| Other Stockholder Equity | 149.093M | 150.42M | 14.382M | 6.357M | 0.107M |
| Property Plant Equipment | - | - | 4.979M | 0.729M | 0.435M |
| Total Current Assets | 21.364M | 31.155M | 47.943M | 17.634M | 0.462M |
| Long Term Investments | 0M | 0.73M | 2.67M | - | - |
| Short Term Investments | - | -0.729M | - | - | - |
| Net Receivables | 7.103M | 10.551M | 5.597M | 1.224M | 0.111M |
| Long Term Debt | - | - | - | 0.069M | - |
| Inventory | 8.508M | 10.089M | 3.03M | 0.54M | - |
| Accounts Payable | 5.111M | 7.748M | 5.628M | 1.809M | 0.328M |
| Accumulated Other Comprehensive Income | -0.14M | -2.732M | -1.108M | 0.039M | 0.023M |
| Non Currrent Assets Other | 0.08M | 0.287M | 0.097M | - | 0.277M |
| Non Current Assets Total | 2.262M | 49.832M | 37.536M | 1.818M | 0.711M |
| Capital Lease Obligations | 1.741M | 3.057M | 1.32M | 0.329M | 0.299M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Investments | -15.802M | -2.509M | -2.164M | -2.509M |
| Total Cashflows From Investing Activities | - | -14.55M | -2.164M | -0.517M |
| Total Cash From Financing Activities | 4.413M | 58.106M | 25.816M | 1.206M |
| Net Income | -52.629M | -21.361M | -14.334M | -3.389M |
| Change In Cash | -28.079M | 22.091M | 15.383M | 0.168M |
| Begin Period Cash Flow | 37.616M | 15.523M | 0.14M | - |
| End Period Cash Flow | 9.537M | 37.614M | 15.523M | 0.14M |
| Total Cash From Operating Activities | -15.935M | -20.648M | -8.421M | -0.545M |
| Depreciation | 2.629M | 0.765M | 0.113M | 0.031M |
| Other Cashflows From Investing Activities | - | - | - | - |
| Dividends Paid | - | 2.507M | 0M | - |
| Change To Inventory | 1.219M | -1.141M | -0.055M | -0.055M |
| Sale Purchase Of Stock | -0.255M | 2.507M | - | - |
| Other Cashflows From Financing Activities | 0.313M | 16.004M | -3.104M | 1.255M |
| Capital Expenditures | 1.294M | 3.983M | 0.234M | 0.168M |
| Change In Working Capital | 3.824M | -5.037M | -0.947M | - |
| Other Non Cash Items | 28.375M | 3.743M | 0.03M | - |
| Free Cash Flow | -17.229M | -24.631M | -8.655M | - |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | SG Actions US Techno C | 2 years ago | 100000 |
| 2. | Fidelity Extended Market Index | 2 years ago | 31929 |
| 3. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 27987 |
| 4. | NT Ext Equity Mkt Idx Fd - L | 2 years ago | 7719 |
| 5. | Northern Trust Extended Eq Market Idx | 2 years ago | 7719 |
| 6. | Fidelity Nasdaq Composite Index | 2 years ago | 4049 |
| 7. | Fidelity Series Total Market Index | 2 years ago | 4026 |
| 8. | NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 2 years ago | 314 |
| 9. | Fidelity U.S. Equity Index Ins Trust | 2 years ago | 81 |
| 10. | Medical Cannabis and Wellness ETF Acc | 2 years ago | 1 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Mirae Asset Global Investments (Korea) Co Ltd | 2 years ago | 988368 |
| 2. | Renaissance Technologies Corp | 2 years ago | 60613 |
| 3. | Geode Capital Management, LLC | 2 years ago | 36295 |
| 4. | Vanguard Group Inc | 2 years ago | 23061 |
| 5. | XTX Topco Ltd | 2 years ago | 12205 |
| 6. | Tower Research Capital LLC | 2 years ago | 6367 |
| 7. | UBS Group AG | 2 years ago | 2556 |
| 8. | Royal Bank of Canada | 2 years ago | 749 |
| 9. | Advisor Group Holdings, Inc. | 2 years ago | 421 |
| 10. | Morgan Stanley - Brokerage Accounts | 2 years ago | 276 |
| 11. | VIMA LLC | 2 years ago | 197 |
| 12. | Advisory Services Network, LLC | 2 years ago | 116 |
| 13. | Hanson Mcclain Inc | 2 years ago | 72 |
| 14. | Castleview Partners, LLC | 2 years ago | 69 |
| 15. | Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 years ago | 60 |
| 16. | Wells Fargo & Co | 2 years ago | 55 |
| 17. | Gradient Investments | 2 years ago | 50 |
| 18. | Toth Financial Advisory Corp | 2 years ago | 45 |
| 19. | Bank of America Corp | 2 years ago | 39 |
| 20. | PNC Financial Services Group Inc | 2 years ago | 38 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...